UncategorizedCortechs.ai acquires ZepMed IP to boost neuroimaging tools – Longevity.Technology Empower Meds / October 16, 2025
UncategorizedCymbiotika arrives at Target in first major retail expansion – Longevity.Technology Empower Meds / October 16, 2025
UncategorizedVasa Therapeutics gains FDA clearance for VS-041 IND – Longevity.Technology Empower Meds / October 16, 2025
UncategorizedMinovia secures orphan drug status for MNV-201 in MDS – Longevity.Technology Empower Meds / October 16, 2025
UncategorizedLongevity Show launch heralds a new era of healthy longevity Empower Meds / October 16, 2025
UncategorizedCumulus presents new digital biomarker data at two neuroscience conferences – Longevity.Technology Empower Meds / October 15, 2025
UncategorizedAlzheon publishes peer-reviewed data from APOLLOE4 Phase 3 trial – Longevity.Technology Empower Meds / October 15, 2025
UncategorizedPeloton teams up with digital twin platform on metabolic health Empower Meds / October 15, 2025
